Variable | All patients (n = 268) | Without warfarin (n = 180) | ||||
---|---|---|---|---|---|---|
AUC | 95% CI | P value | AUC | 95% CI | P value | |
CHA2DS2-VASc components | ||||||
CHF (yes) | 0.49 | 0.40–0.58 | 0.84 | 0.46 | 0.35–0.58 | 0.52 |
Hypertension (Yes) | 0.50 | 0.41–0.60 | 0.95 | 0.49 | 0.38–0.60 | 0.84 |
Age ≥ 75 years (yes) | 0.49 | 0.40–0.58 | 0.78 | 0.47 | 0.36–0.58 | 0.62 |
DM (yes) | 0.54 | 0.45–0.63 | 0.36 | 0.52 | 0.41–0.64 | 0.68 |
Prior stroke or TIA (yes) | 0.67 | 0.58–0.76 | < 0.001 | 0.67 | 0.56–0.78 | 0.003 |
Vascular disease (yes) | 0.50 | 0.40–0.59 | 0.92 | 0.49 | 0.38–0.61 | 0.91 |
Age 65–74 years (yes) | 0.52 | 0.43–0.61 | 0.66 | 0.51 | 0.40–0.63 | 0.81 |
Sex (female) | 0.52 | 0.42–0.61 | 0.71 | 0.48 | 0.37–0.59 | 0.73 |
CHA2DS2-VASc score | 0.63 | 0.54–0.72 | 0.006 | 0.59 | 0.48–0.70 | 0.11 |
HAS-BLED components | ||||||
Hypertension (yes) | 0.46 | 0.33–0.59 | 0.50 | 0.45 | 0.29–0.61 | 0.54 |
Abnormal renal function (yes) | 0.50 | 0.35–0.65 | 1.00 | 0.50 | 0.35–0.65 | 1.00 |
Abnormal liver function (yes) | 0.51 | 0.38–0.63 | 0.92 | 0.51 | 0.36–0.67 | 0.85 |
Prior stroke (yes) | 0.44 | 0.32–0.55 | 0.31 | 0.43 | 0.29–0.57 | 0.37 |
Prior major bleeding (yes) | 0.59 | 0.47–0.72 | 0.15 | 0.60 | 0.45–0.76 | 0.19 |
Labile INR (yes) | 0.49 | 0.38–0.62 | 0.95 | 0.50 | 0.34–0.65 | 0.96 |
Age > 65 years (yes) | 0.40 | 0.27–0.52 | 0.09 | 0.47 | 0.31–0.63 | 0.71 |
Prior alcohol or drug usage (yes) | 0.53 | 0.40–0.65 | 0.68 | 0.52 | 0.36–0.68 | 0.81 |
Medication usage predisposing to bleeding (yes) | 0.46 | 0.31–0.52 | 0.55 | 0.54 | 0.39–0.69 | 0.58 |
HAS-BLED score | 0.47 | 0.35–0.57 | 0.62 | 0.49 | 0.34–0.65 | 0.94 |